Is Compounded Semaglutide the Same as Mounjaro?

Last reviewed: June 9, 2026

Last updated: June 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Many patients assume all GLP-1 medications work identically, but compounded semaglutide and Mounjaro (tirzepatide) target different biological pathways. Semaglutide activates one hormone receptor, while tirzepatide activates two, producing distinct metabolic effects. PlexusDx offers both options to match your individual genetics and health profile.

What Makes Semaglutide and Tirzepatide Chemically Different

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, meaning it mimics the GLP-1 hormone your body naturally produces to regulate blood sugar and appetite. Tirzepatide, the active ingredient in Mounjaro, is a dual GIP/GLP-1 receptor agonist—it activates both the GIP receptor and the GLP-1 receptor simultaneously. This dual-action approach engages additional metabolic pathways that single-receptor medications cannot reach.

The structural difference between these compounds affects how your body processes them and responds over time. Semaglutide was developed first and has a longer track record in clinical use, while tirzepatide represents a newer generation of precision peptide therapy designed to address multiple hormone pathways. Neither medication is identical at the molecular level, which is why clinical outcomes and individual tolerability vary between patients taking each drug.

How Compounded Semaglutide Injections Work in Your Body

Compounded semaglutide from licensed 503A compounding pharmacies mimics the pharmaceutical-grade version by binding to GLP-1 receptors in your brain and digestive system. Once activated, these receptors slow gastric emptying, increase feelings of fullness, and reduce hunger-driven eating behavior. Additionally, semaglutide enhances insulin secretion when blood glucose rises, supporting metabolic stability without causing dangerous blood sugar drops.

Clinical trials demonstrate that semaglutide produces meaningful weight loss through appetite suppression and modest increases in energy expenditure. Patients typically experience the most noticeable effects within the first 4–8 weeks as their dose gradually increases. The injectable form reaches systemic circulation more quickly than oral alternatives, allowing for more predictable dosing schedules and faster symptom onset.

Tirzepatide (Mounjaro) and Its Dual-Hormone Mechanism

Tirzepatide activates both GIP and GLP-1 receptors, creating a synergistic effect that semaglutide alone cannot achieve. The GIP pathway regulates glucose-dependent insulin secretion and may influence fat storage and energy balance through distinct brain regions. When combined with GLP-1 activation, the dual approach addresses appetite, metabolism, and insulin sensitivity through multiple simultaneous channels.

Clinical evidence shows tirzepatide produces greater average weight loss than semaglutide monotherapy in head-to-head comparisons. A pivotal trial reported that patients on the highest tirzepatide dose lost approximately 22% of baseline body weight over 72 weeks, compared to 16% with semaglutide at its highest dose. However, individual responses vary based on genetic predispositions, lifestyle factors, and underlying metabolic conditions. PlexusDx offers tirzepatide injections at $289/mo month-to-month, or from $249/mo on the 6-month plan, with the understanding that your dose may need to go up—your price won't.

Personalized Selection: Which Medication Fits Your Genetics

The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Patients with genetic variants that enhance GLP-1 receptor sensitivity may achieve excellent results with compounded semaglutide, avoiding unnecessary cost and side effects from dual-receptor activation. Conversely, individuals whose genetic makeup shows reduced GLP-1 responsiveness or elevated FTO-driven appetite drive may benefit significantly from tirzepatide's dual mechanism. The $298 Precision Peptide Genetic Test provides 150+ clinical insights across 49 peptides and 14 metabolic pathways, enabling your PlexusDx clinician to recommend the medication most likely to work for your body.

Side Effects and Tolerability: Semaglutide vs. Tirzepatide

Both medications cause gastrointestinal effects during dose escalation, including nausea, vomiting, and constipation. Semaglutide-related side effects typically resolve within 1–2 weeks as your digestive system adapts; tirzepatide may produce similar patterns, though some patients experience longer adjustment periods due to dual-receptor stimulation. Serious adverse events are rare with either medication when administered under medical supervision.

Pancreatitis, thyroid concerns, and gallbladder issues have been documented in clinical trial data for both drug classes, though incidence rates remain low in real-world use. Individual tolerance varies—some patients find semaglutide causes excessive nausea, while others thrive on it and tolerate tirzepatide poorly. PlexusDx clinicians monitor your symptoms and adjust your treatment plan if either medication produces intolerable effects, ensuring your weight loss journey remains safe and sustainable.

Cost, Access, and Convenience with PlexusDx

PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan across all commitment tiers, while compounded tirzepatide injections begin at $289/mo (or $249/mo on the 6-month plan). Both medications are dispensed from licensed 503A compounding pharmacies, comply with state regulations in all 50 states, and require no insurance or membership fees. HSA and FSA accounts cover both options, increasing affordability for eligible patients.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is compounded semaglutide the same strength as brand-name semaglutide?

Compounded semaglutide from licensed 503A pharmacies contains identical active pharmaceutical ingredients and achieves the same therapeutic effects as brand products. The key difference is sourcing and cost—PlexusDx compounded versions are $189/mo month-to-month, or from $149/mo on the 6-month plan without insurance, making precision weight loss therapy more accessible while maintaining clinical efficacy.

Will tirzepatide work better for weight loss than semaglutide?

Clinical trials show tirzepatide produces greater average weight loss, but individual results depend on your genetics, lifestyle, and metabolic health. PlexusDx uses the Precision Peptide Genetic Test to analyze your GIPR variants, predicting whether semaglutide or tirzepatide will deliver superior outcomes for your specific body.

Can I switch from semaglutide to tirzepatide if I'm not seeing results?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Are there serious side effects unique to one medication?

Both semaglutide and tirzepatide carry similar safety profiles—nausea, constipation, and rare pancreatitis risk. Tirzepatide's dual-receptor activation may cause slightly more GI effects during dose escalation in some patients. PlexusDx monitors your tolerance closely and adjusts your regimen if either medication produces intolerable symptoms, prioritizing your safety and comfort.

How does the Precision Peptide Genetic Test help choose between these medications?

The test analyzes 150+ genetic insights across GLP-1 and GIP pathways, revealing your predicted sensitivity to each receptor. Variants in GIPR, FTO, and MC4R determine whether semaglutide's single-pathway approach or tirzepatide's dual mechanism will activate your weight loss biology most effectively, guiding your PlexusDx clinician toward the optimal starting medication.

Related Reading

• Compounded Semaglutide 2
• Compounded Mounjaro
• Is Semaglutide The Same As Ozempic
• Compounded Semaglutide

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.